Neoadjuvant Radiation Case Volume Is Associated with Improved Margin-Negative Resection Rate in Patients with Pancreatic Cancer

被引:0
|
作者
Thalji, Sam [1 ]
Erickson, Beth A. [1 ]
Aldakkak, Mohammed [1 ]
Christians, Kathleen K. [1 ]
Clarke, Callisia [1 ]
Doucette, Saryn [1 ]
Evans, Douglas B. [1 ]
Tsai, Susan [1 ]
机构
[1] Med Coll Wisconsin, Milwaukee, WI USA
关键词
D O I
10.1097/01.XCS.0000894140.67093.91
中图分类号
R61 [外科手术学];
学科分类号
摘要
引用
收藏
页码:S152 / S152
页数:1
相关论文
共 50 条
  • [21] Calcium channel blockers are associated with improved survival in pancreatic cancer patients undergoing neoadjuvant chemotherapy and resection
    Fong, Zhi
    Severs, George
    Moir, John
    White, Steve
    Qadan, Motaz
    Tingle, Samuel
    BRITISH JOURNAL OF SURGERY, 2024, 111
  • [22] Neoadjuvant therapy prior to surgical resection for previously explored pancreatic cancer patients is associated with improved survival
    Lu, Fengchun
    Soares, Kevin C.
    He, Jin
    Javed, Ammar A.
    Cameron, John L.
    Rezaee, Neda
    Pawlik, Timothy M.
    Wolfgang, Christopher L.
    Weiss, Matthew J.
    HEPATOBILIARY SURGERY AND NUTRITION, 2017, 6 (03) : 144 - 153
  • [23] Adjuvant chemotherapy and outcomes in patients with nodal and resection margin-negative pancreatic ductal adenocarcinoma: A systematic review and meta-analysis
    Flaum, Nicola
    Hubner, Richard A.
    Valle, Juan W.
    Amir, Eitan
    McNamara, Mairead G.
    JOURNAL OF SURGICAL ONCOLOGY, 2019, 119 (07) : 932 - 940
  • [24] Strategy for SMA Margin-negative Dissection Without Severe Diarrhea for Pancreatic Uncinate Process Cancer
    Kitagawa, H.
    Hashida, K.
    Hamai, K.
    Kawamoto, K.
    Terakawa, H.
    Ozaki, N.
    PANCREAS, 2019, 48 (10) : 1463 - 1463
  • [25] Factors affecting resection rate in patients undergoing neoadjuvant therapy for pancreatic cancer
    Khawandanah, M.
    Chimpiri, R.
    Kurkjian, C.
    Herman, T. S.
    Qubaiah, O. M.
    Postier, R.
    Ghabach, B.
    Thompson, D.
    Pant, S.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [26] Impact of resection margin status on survival in pancreatic cancer patients after neoadjuvant treatment and pancreatoduodenectomy
    Maeda, Shimpei
    Moore, Alexandra M.
    Yohanathan, Lavanya
    Hata, Tatsuo
    Truty, Mark J.
    Smoot, Rory L.
    Cleary, Sean P.
    Nagorney, David M.
    Grotz, Travis E.
    Park, Eugene J.
    Girgis, Mark D.
    Reber, Howard A.
    Motoi, Fuyuhiko
    Masuda, Toshiro
    Unno, Michiaki
    Kendrick, Michael L.
    Donahue, Timothy R.
    SURGERY, 2020, 167 (05) : 803 - 811
  • [27] Neoadjuvant Therapy for Achieving Margin Negative Resection in Borderline Resectable Pancreatic Ductal Adenocarcinoma
    Chandrasekaran, S.
    Coveler, A. L.
    Chandrasekaran, S.
    Lucas, F. R.
    Patel, S.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2013, 87 (02): : S314 - S314
  • [28] Neoadjuvant Chemotherapy is Associated with Improved Disease-Free Survival in Pancreatic Cancer Patients Undergoing Pancreaticoduodenectomy with Vascular Resection
    Park, Joon
    Dillon, Dustin
    Mederos, Michael
    Seo, Youngji
    King, Jonathan
    Hines, Joe
    Donahue, Timothy
    Girgis, Mark
    ANNALS OF SURGICAL ONCOLOGY, 2022, 29 (SUPPL 2) : 448 - 448
  • [29] Neoadjuvant chemotherapy is associated with improved disease-free survival in pancreatic cancer patients undergoing pancreaticoduodenectomy with vascular resection
    Dillon, Dustin L.
    Park, Joon Y.
    Mederos, Michael A.
    Seo, Young-Ji
    King, Jonathan
    Hines, Joe
    Donahue, Timothy
    Girgis, Mark D.
    JOURNAL OF SURGICAL ONCOLOGY, 2024, 130 (01) : 72 - 82
  • [30] Simvastatin is Associated With Improved Survival in Patients Undergoing Resection for Pancreatic Cancer
    Chang, J. I.
    Jeon, C. Y.
    Pandol, S. J.
    Wu, B. U.
    PANCREAS, 2014, 43 (08) : 1347 - 1348